| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $62K | — |
| SG&A Expense | $7.6M | +70.3% |
| Operating Income | -$8.1M | -80.6% |
| Income Tax | $912 | — |
| Net Income | -$9.1M | -100.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $317K | -58.8% |
| Total Assets | $1.8M | +40.5% |
| Current Liabilities | $13.3M | +113.8% |
| Total Liabilities | $14.5M | +121.4% |
| Stockholders' Equity | -$12.7M | -141.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.0M | -47.7% |
| Capital Expenditures | $988K | +2055.5% |
| Investing Cash Flow | -$988K | -2055.5% |
| Financing Cash Flow | $3.1M | +128.9% |
| Free Cash Flow | -$2.9M | -114.9% |